U.S. Bioanalytical Testing Services Market Size, Share & Trends Analysis Report By Molecule (Small Molecule, Large Molecule), By Test, By Workflow, By End-use (Pharma & BioPharma Companies, CDMO, CRO), And Segment Forecasts, 2025 - 2030

Table of Contents

Chapter 1. Research Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Segment Definitions
                        1.2.1. Molecule
                        1.2.2. Test
                        1.2.3. Workflow
                        1.2.4. End Use
                    1.3. Research Methodology
                    1.4. Information Procurement
                        1.4.1. Purchased Database
                        1.4.2. GVR’s Internal Database
                        1.4.3. Secondary Sources
                        1.4.4. Primary Research
                    1.5. Information Or Data Analysis
                        1.5.1. Data Analysis Models
                    1.6. Market Formulation & Validation
                    1.7. Model Details
                        1.7.1. Commodity Flow Analysis
                        1.7.2. Parent Market Analysis
                    1.8. List Of Secondary Sources
                    1.9. List Of Abbreviations
                    1.10. Objectives
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                    2.3. Competitive Insights
Chapter 3. U.S. Bioanalytical Testing Services Market Variables, Trends & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent Market Outlook
                        3.1.2. Related/Ancillary Market Outlook
                    3.2. Market Dynamics
                        3.2.1. Market Driver Analysis
                            3.2.1.1. Technological Advancements & Growing R&D Investments
                            3.2.1.2. Regulatory Control and Increasing Awareness Regarding Bioanalytical Testing
                            3.2.1.3. Expansion of Bioanalytical Testing Facilities
                        3.2.2. Market Restraint Analysis
                            3.2.2.1. Compliance Issues While Outsourcing
                            3.2.2.2. Data Security Concerns
                    3.3. Investments & Funding Perspective
                    3.4. Clinical Trials Volume Analysis, (2024)
                        3.4.1. Total Number Of Clinical Trials By Region (2024)
                        3.4.2. Total Number Of Clinical Trials, By Phase (2024)
                        3.4.3. Total Number Of Clinical Trials, By Study Design (2024)
                        3.4.4. Total Number Of Clinical Trials, By Key Therapeutic Area (2024)
                    3.5. Pricing Model Analysis
                    3.6. Technology Landscape
                    3.7. Regulatory Framework
                    3.8. Market Analysis Tools
                        3.8.1. Porter’s Five Force Analysis
                        3.8.2. PESTEL by SWOT Analysis
                        3.8.3. COVID-19 Impact Analysis
Chapter 4. U.S. Bioanalytical Testing Services Market: Molecule Estimates & Trend Analysis
                    4.1. U.S. Bioanalytical Testing Services Market, By Molecule: Segment Dashboard
                    4.2. U.S. Bioanalytical Testing Services Market, By Molecule: Movement Analysis
                    4.3. U.S. Bioanalytical Testing Services Market Estimates & Forecasts, By Molecule, 2018 - 2030 (USD Million)
                    4.4. Small Molecule
                        4.4.1. Small Molecule Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    4.5. Large Molecule
                        4.5.1. Large Molecule Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        4.5.2. LC-MS Studies
                            4.5.2.1. LC-MS Studies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        4.5.3. Immunoassays
                            4.5.3.1. Immunoassays Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                            4.5.3.2. Pharmacokinetics (PK)
                                4.5.3.2.1. Pharmacokinetics (PK) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                            4.5.3.3. ADA Assay
                                4.5.3.3.1. ADA Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                            4.5.3.4. Other
                                4.5.3.4.1. Other Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        4.5.4. Other Large Molecule Tests
                            4.5.4.1. Other Large Molecule Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. U.S. Bioanalytical Testing Services Market: Test Estimates & Trend Analysis
                    5.1. U.S. Bioanalytical Testing Services Market, By Test: Segment Dashboard
                    5.2. U.S. Bioanalytical Testing Services Market, By Test: Movement Analysis
                    5.3. U.S. Bioanalytical Testing Services Market Estimates & Forecasts, By Test, 2018 - 2030 (USD Million)
                    5.4. ADME
                        5.4.1. ADME Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.4.2. In-vivo
                            5.4.2.1. In-vivo Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.4.3. In-vitro
                            5.4.3.1. In-vitro Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    5.5. Pharmacokinetics (PK)
                        5.5.1. Pharmacokinetics (PK) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    5.6. Pharmacodynamics (PD)
                        5.6.1. Pharmacodynamics (PD) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    5.7. Bioavailability
                        5.7.1. Bioavailability Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    5.8. Bioequivalence
                        5.8.1. Bioequivalence Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    5.9. Biomarker Testing
                        5.9.1. Biomarker Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    5.10. Cell-based Assay
                        5.10.1. Cell-based Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    5.11. Virology Testing
                        5.11.1. Virology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    5.12. Other Tests
                        5.12.1. Other Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. U.S. Bioanalytical Testing Services Market: Workflow Estimates & Trend Analysis
                    6.1. U.S. Bioanalytical Testing Services Market, By Workflow: Segment Dashboard
                    6.2. U.S. Bioanalytical Testing Services Market, By Workflow Movement Analysis
                    6.3. U.S. Bioanalytical Testing Services Market Estimates & Forecasts, By Workflow, 2018 - 2030 (USD Million)
                    6.4. Sample Collection and Preparation
                        6.4.1. Sample Collection and Preparation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        6.4.2. Sample Collection, Handling and Storage
                            6.4.2.1. Sample Collection, Handling and Storage Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        6.4.3. Protein Precipitation
                            6.4.3.1. Protein Precipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        6.4.4. Liquid-Liquid Extraction
                            6.4.4.1. Liquid-Liquid Extraction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        6.4.5. Solid Phase Extraction
                            6.4.5.1. Solid Phase Extraction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        6.4.6. Others
                            6.4.6.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    6.5. Method Development and Validation
                        6.5.1. Method Development and Validation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    6.6. Sample Analysis
                        6.6.1. Sample Analysis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        6.6.2. Hyphenated Technique
                            6.6.2.1. Hyphenated Technique Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        6.6.3. Chromatographic technique
                            6.6.3.1. Chromatographic Technique Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        6.6.4. Electrophoresis
                            6.6.4.1. Electrophoresis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        6.6.5. Ligand Binding Assay
                            6.6.5.1. Ligand Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        6.6.6. Mass Spectrometry
                            6.6.6.1. Mass Spectrometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        6.6.7. Spectroscopic Techniques
                            6.6.7.1. Spectroscopic Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                            6.6.7.2. Nuclear Magnetic Resonance (NMR)
                                6.6.7.2.1. Nuclear Magnetic Resonance (NMR) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                            6.6.7.3. Others
                                6.6.7.3.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        6.6.8. Genomic and Molecular Techniques
                            6.6.8.1. Genomic and Molecular Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                            6.6.8.2. Polymerase Chain Reaction (PCR)
                                6.6.8.2.1. Polymerase Chain Reaction (PCR) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                            6.6.8.3. Next-Generation Sequencing (NGS)
                                6.6.8.3.1. Next-Generation Sequencing (NGS) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                            6.6.8.4. Others
                                6.6.8.4.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    6.7. Other Processes
                        6.7.1. Other Processes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. U.S. Bioanalytical Testing Services Market: End Use Estimates & Trend Analysis
                    7.1. U.S. Bioanalytical Testing Services Market, By End Use: Segment Dashboard
                    7.2. U.S. Bioanalytical Testing Services Market, By End Use: Movement Analysis
                    7.3. U.S. Bioanalytical Testing Services Market Estimates & Forecasts, By End Use, 2018 - 2030 (USD Million)
                    7.4. Pharma & BioPharma Companies
                        7.4.1. Pharma & BioPharma Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    7.5. CDMO
                        7.5.1. CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    7.6. CRO
                        7.6.1. CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                    7.7. Others
                        7.7.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
                    8.1. Market Participant Categorization
                    8.2. Company Market Share/Assessment Analysis, 2024
                    8.3. Company Profiles
                        8.3.1. Thermo Fisher Scientific, Inc.
                            8.3.1.1. Company Overview
                            8.3.1.2. Financial Performance
                            8.3.1.3. Service Benchmarking
                            8.3.1.4. Strategic Initiatives
                        8.3.2. ICON plc
                            8.3.2.1. Company Overview
                            8.3.2.2. Financial Performance
                            8.3.2.3. Service Benchmarking
                            8.3.2.4. Strategic Initiatives
                        8.3.3. Charles River Laboratories International, Inc.
                            8.3.3.1. Company Overview
                            8.3.3.2. Financial Performance
                            8.3.3.3. Service Benchmarking
                            8.3.3.4. Strategic Initiatives
                        8.3.4. Laboratory Corporation of America Holdings.
                            8.3.4.1. Company Overview
                            8.3.4.2. Financial Performance
                            8.3.4.3. Service Benchmarking
                            8.3.4.4. Strategic Initiatives
                        8.3.5. IQVIA Inc.
                            8.3.5.1. Company Overview
                            8.3.5.2. Financial Performance
                            8.3.5.3. Service Benchmarking
                            8.3.5.4. Strategic Initiatives
                        8.3.6. Syneos Health
                            8.3.6.1. Company Overview
                            8.3.6.2. Financial Performance
                            8.3.6.3. Service Benchmarking
                            8.3.6.4. Strategic Initiatives
                        8.3.7. SGS SA
                            8.3.7.1. Company Overview
                            8.3.7.2. Financial Performance
                            8.3.7.3. Service Benchmarking
                            8.3.7.4. Strategic Initiatives
                        8.3.8. Intertek Group Plc
                            8.3.8.1. Company Overview
                            8.3.8.2. Financial Performance
                            8.3.8.3. Service Benchmarking
                            8.3.8.4. Strategic Initiatives
                        8.3.9. Pace Analytical Services, LLC
                            8.3.9.1. Company Overview
                            8.3.9.2. Financial Performance
                            8.3.9.3. Service Benchmarking
                            8.3.9.4. Strategic Initiatives
                        8.3.10. Medpace Holdings, Inc.
                            8.3.10.1. Company Overview
                            8.3.10.2. Financial Performance
                            8.3.10.3. Service Benchmarking
                            8.3.10.4. Strategic Initiatives
                        8.3.11. North America Science Associates Inc. (NAMSA)
                            8.3.11.1. Company Overview
                            8.3.11.2. Financial Performance
                            8.3.11.3. Service Benchmarking
                            8.3.11.4. Strategic Initiatives

List of Tables

Table 1 List of abbreviation
Table 2 U.S. Bioanalytical Testing Services Market Estimates and Forecasts, by Molecule, 2018 - 2030 (USD Million)
Table 3 U.S. Bioanalytical Testing Services Market Estimates and Forecasts, by Large Molecule Tests, 2018 - 2030 (USD Million)
Table 4 U.S. Bioanalytical Testing Services Market Estimates and Forecasts, by Large Molecule Immunoassay Tests, 2018 - 2030 (USD Million)
Table 5 U.S. Bioanalytical Testing Services Market Estimates and Forecasts, by Test, 2018 - 2030 (USD Million)
Table 6 U.S. Bioanalytical Testing Services Market Estimates and Forecasts, by ADME Test, 2018 - 2030 (USD Million)
Table 7 U.S. Bioanalytical Testing Services Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
Table 8 U.S. Bioanalytical Testing Services Market Estimates and Forecasts, by Sample Collection and Preparation, 2018 - 2030 (USD Million)
Table 9 U.S. Bioanalytical Testing Services Market Estimates and Forecasts, by Sample Analysis, 2018 - 2030 (USD Million)
Table 10 U.S. Bioanalytical Testing Services Market Estimates and Forecasts, by Spectroscopic Techniques, 2018 - 2030 (USD Million)
Table 11 U.S. Bioanalytical Testing Services Market Estimates and Forecasts, by Genomic and Molecular Techniques, 2018 - 2030 (USD Million)
Table 12 U.S. Bioanalytical Testing Services Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
Table 13 Financial performance

List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Market formulation & validation
Fig. 6 Commodity flow analysis
Fig. 7 Value-chain-based sizing & forecasting
Fig. 8 QFD model sizing & forecasting
Fig. 9 Bottom-up approach
Fig. 10 Market snapshot
Fig. 11 Segment snapshot 1
Fig. 12 Segment snapshot 2
Fig. 13 Competitive landscape snapshot
Fig. 14 Parent market outlook, 2024 (USD Billion)
Fig. 15 Ancillary market outlook, 2024 (USD Billion)
Fig. 16 U.S. Bioanalytical Testing Services Market dynamics
Fig. 17 Porter’s Five Forces Analysis
Fig. 18 PESTEL analysis
Fig. 19 U.S. Bioanalytical Testing Services Market: Molecule Outlook and Key Takeaways
Fig. 20 U.S. Bioanalytical Testing Services Market: Molecule Movement Analysis
Fig. 21 Small Molecule Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 22 Large Molecule Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 23 LC-MS Studies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 24 Immunoassays Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 25 Pharmacokinetics (PK) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 26 ADA Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 27 Other Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 28 Other Large Molecule Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 29 U.S. Bioanalytical Testing Services Market: Test Outlook and Key Takeaways
Fig. 30 U.S. Bioanalytical Testing Services Market: Test Movement Analysis
Fig. 31 ADME Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 32 In-vivo Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 33 In-vitro Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 34 Pharmacokinetics (PK) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 35 Pharmacodynamics (PD) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 36 Bioavailability Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 37 Bioequivalence Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 38 Biomarker Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 39 Cell-based Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 40 Virology Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 41 Other Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 42 U.S. Bioanalytical Testing Services Market: Workflow Outlook and Key Takeaways
Fig. 43 U.S. Bioanalytical Testing Services Market: Workflow Movement Analysis
Fig. 44 Sample Collection and Preparation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 45 Sample Collection, Handling and Storage Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 46 Protein Precipitation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 47 Liquid-Liquid Extraction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 48 Solid Phase Extraction Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 49 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 50 Method Development and Validation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 51 Sample Analysis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 52 Hyphenated technique Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 53 Chromatographic technique Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 54 Electrophoresis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 55 Ligand Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 56 Mass Spectrometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 57 Spectroscopic Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 58 Nuclear Magnetic Resonance (NMR) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 59 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 60 Genomic and Molecular Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 61 Polymerase Chain Reaction (PCR) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 62 Next-Generation Sequencing (NGS) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 63 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 64 Other Processes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 65 U.S. Bioanalytical Testing Services Market: End Use outlook and key takeaways
Fig. 66 U.S. Bioanalytical Testing Services Market: End Use movement analysis
Fig. 67 Pharma & BioPharma Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 68 CDMO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 69 CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 70 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Fig. 71 Key company categorization
Fig. 72 Service heat map analysis
Fig. 73 Strategic framework